DISC MEDICINE INC. -

64,80

06-ноября-24 15:59:57

15 мин. задержка

Акции

+0,02

+0,04%

Сегодняшний диапазон

64,09 - 67,79

ISIN

N/A

Источник

NASDAQ

Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

05 ноя 2024 09:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

04 ноя 2024 07:50:00 Источник Nasdaq GlobeNewswire
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

01 ноя 2024 16:01:00 Источник Nasdaq GlobeNewswire
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week

25 окт 2024 13:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer

23 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

11 окт 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Steve Caffé, MD as Chief Regulatory Officer

19 сен 2024 08:30:00 Источник Nasdaq GlobeNewswire
Disc Medicine to Participate in Upcoming Investor Conferences

30 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Reports Second Quarter 2024 Financial Results and Provides Business Update

08 авг 2024 08:00:01 Источник Nasdaq GlobeNewswire
Disc Medicine Announces Underwritten Offering of Common Stock

14 июн 2024 08:03:53 Источник Nasdaq GlobeNewswire
Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress

14 июн 2024 07:30:00 Источник Nasdaq GlobeNewswire
Disc Medicine to Participate in the Jefferies Global Healthcare Conference

30 май 2024 09:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress

14 май 2024 10:30:00 Источник Nasdaq GlobeNewswire
Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference

13 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update

09 май 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)

01 апр 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

21 мар 2024 08:00:00 Источник Nasdaq GlobeNewswire
Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024

06 мар 2024 16:30:00 Источник Nasdaq GlobeNewswire
Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer

26 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire
Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease

20 фев 2024 08:30:00 Источник Nasdaq GlobeNewswire

<<
<
1
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.